BioSpace News Archive

Business

Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results

Management to host a conference call and webcast at 8:30 a.m. eastern time today.

December 15, 2017
·
5 min read
Business

Esperion Announces the Appointment of Jeffrey Berkowitz to Board of Directors

Mr. Berkowitz is the former executive vice president of Optum.

December 15, 2017
·
6 min read
Policy

QIAGEN and Oxford Immunotec Settle Patent Infringement Lawsuit

Under terms of the agreement, all pending claims between Oxford and QIAGEN and the co-defendants have been resolved.

December 15, 2017
·
1 min read
Drug Development

ASIT Biotech Reviews the Efficacy Results of gp-ASIT+

The results presented to the EAACI show that over the course of the whole pollen season, gp-ASIT+ resulted in an average reduction in the combined score of 17.9% for the entire study population, close to the threshold of 20% required by the registration authorities.

December 15, 2017
·
2 min read
Biotech Bay

Avinger Secures Waiver and Consent to CRG Loan Agreement

The PIK loan allows Avinger to conserve cash usage by increasing the principal amount of the loan.

December 15, 2017
·
1 min read
Genetown

Acer Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

Acer intends to use the net proceeds from this offering to fund its research and development efforts, to seek regulatory approval for EDSIVO and more.

December 15, 2017
·
4 min read
Elekta Collaborates With Palabra to Offer the Industry’s Only Voice-Endable EHR

The integrated system has been installed in sites in North America and Australia.

December 15, 2017
·
2 min read
FDA

Aclaris Nabs FDA Approval for ESKATA Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)

SKs are non-cancerous skin growths that affect more than 83 million American adults and can be an aesthetic skin concern.

December 15, 2017
·
7 min read
Genetown

Blueprint Medicines Company Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock

Goldman Sachs & Co. LLC, Morgan Stanley and Cowen acted as joint book-running managers for the offering.

December 15, 2017
·
4 min read
Business

NOTICE TO THE MARKET: Grupo Biotoscana Announces Hiring of Executive VP of R&D

Grupo Biotoscana announces to its shareholders and the market in general that has hired Ivan French as Executive VP of Research and Development.

December 15, 2017
·
2 min read